Your browser doesn't support javascript.
loading
Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma.
Black, Margaret A; Neumann, Neil M; Krings, Gregor; Najjar, Saleh; Troxell, Megan L; Wang, Aihui; Devine, W Patrick; Vohra, Poonam; Gasper, Cynthia; Chen, Yunn-Yi; Cohen, Jarish N; Bean, Gregory R.
Afiliação
  • Black MA; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Neumann NM; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Krings G; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Najjar S; Department of Pathology, King Faisal Specialist Hospital & Research Centre, Saudi Arabia.
  • Troxell ML; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Wang A; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Devine WP; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Vohra P; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Gasper C; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Chen YY; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Cohen JN; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Bean GR; Department of Pathology, Stanford University School of Medicine, Stanford, California. Electronic address: beang@stanford.edu.
Mod Pathol ; 36(10): 100270, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37422157
ABSTRACT
Mucoepidermoid carcinoma (MEC) is exceedingly rare in the breast, with <45 cases reported in the literature. Although estrogen receptor/progesterone receptor/human epidermal growth factor 2 triple-negative, MEC is characterized as a special subtype of breast carcinoma with significantly better prognosis than conventional basal-type tumors. Cutaneous hidradenoma (HA) is considered a benign adnexal neoplasm showing histomorphologic overlap with MEC. Rare cases of HA have also been reported in the breast, but these are relatively uncharacterized. In this study, we examined the clinicopathologic, immunohistochemical (IHC), and genetic features of 8 breast HAs, in comparison to 3 mammary MECs. All cases were positive for MAML2 break-apart fluorescence in situ hybridization. Eight cases demonstrated a CRTC1MAML2 fusion, and one MEC harbored a CRTC3MAML2 fusion; the latter is a novel finding in the breast. Mutational burden was very low, with only one HA exhibiting a MAP3K1 pathogenic alteration. By IHC, both MEC and HA demonstrated cell type-dependent expression of high- and low-molecular-weight keratins and p63, as well as negative to low-positive estrogen receptor and androgen receptor. Smooth muscle myosin and calponin highlighted an in situ component in the 3 cases of MEC; expression of these myoepithelial markers was negative in HAs. Additional distinguishing characteristics included the growth pattern and tumor architecture, the presence of glandular/luminal cells in HA, and overall higher IHC expression of SOX10, S100 protein, MUC4, and mammaglobin in MEC. Morphologic findings were also compared to a series of 27 cutaneous nonmammary HAs. Mucinous and glandular/luminal cells were identified in significantly more mammary HAs than nonmammary lesions. The findings provide insight into the pathogenesis of MAML2-rearranged neoplasms of the breast, underscore the overlapping genetic features of MEC and HA, and highlight similarities to their extramammary counterparts.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article